0
     

Report Added
Report already added
eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026

eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026

The global eClinical Solutions market is projected to reach USD 15.4 billionby 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech companies are some of the major driving factors for the global eClinical solutions market.

Cloud-based (SaaS) segment is projected to record the highest CAGR

Based on delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) solutions. In 2020, the web-hosted (on-demand) segment commanded the largest share of the global eClinical solutions market. The increasing number of cloud-based clinical trial solutions in the market and the rising adoption of these solutions in clinical research studies (owing to advantages such as ease of integration, quicker deployment, and flexible scalability with a fixed monthly fee) are fueling the growth of the cloud-based eClinical solutions market.

Phase III clinical trials is expected to register the highest growth during the forecast period

Based on clinical trial phase, the eClinical solutions market has been segmented into phase I, phase II, phase III, and phase IV trials. The phase III clinical trials segment accounted for the largest share of the eClinical solutions market in 2020. The large share of this segment is attributed to the high demand for eClinical solutions for phase III trials due to the involvement of thousands of patients in this phase.

CROs segment is estimated to record the highest CAGR in the forecast period.

Based on end user, the global eClinical solutions market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions. The pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the eClinical solutions market in 2020. However, the CROs segment is estimated to record the highest CAGR (15.5%) in the next five years. The increasing number of CROs in developed as well as developing countries, and the rising instances of clinical trial outsourcing to specialized clinical research organizations are responsible for the high growth rate of this segment.

North America To Witness Significant Growth From 2021 To 2026

In 2020, North America commanded the largest share of the eClinical solutions market.Increasing government grants to support clinical trials, continuous product development and new product launches by eClinical solution vendors, and growth in the number of partnerships for new drug development are further stimulating the demand for eClinical solutions in this region.

Breakdown of supply-side primary interviews: • By Company Type: Tier 1 – 33%, Tier 2 – 42%, and Tier 3 – 18% • By Designation: C-level – 29%, Director-level – 23%, and Others – 48% • By Region: North America - 35%, Europe – 30%, APAC –26%, Rest of the World –9%

Some of the prominent players in this market are Oracle Corporation (US), Medidata Solutions, Inc. (US), Parexel International Corporation (US), BioClinica, Inc. (US), Signant Health (US), Datatrak International, Inc. (US), ERT (US), eClinical Solutions, Inc. (US), MaxisIT Inc. (US), Bio-Optronics, Inc. (US), Merge Healthcare Incorporated (US), and OmniComm Systems, Inc. (US)

Research coverage

This report describes and studies the eClinical Solutions market based on product, delivery mode, clinical trials phases, end users and region. It provides detailed information regarding the major factors influencing the growth of this market and the factors impacting market dynamics. The report includes in-depth competitive analysis and the product matrix of the prominent players in this market, along with their company profiles, product portfolios, recent developments (mergers, acquisitions, partnerships, collaborations, etc.), and key business strategies.

Key Benefits of Buying the Report

This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
1INTRODUCTION33
1.1OBJECTIVES OF THE STUDY33
1.2MARKET DEFINITION33
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY34
1.2.2MARKETS COVERED35
1.2.3GEOGRAPHIC SCOPE35
1.2.4YEARS CONSIDERED FOR THE STUDY36
1.3CURRENCY36
1.4LIMITATIONS36
1.5MAJOR MARKET STAKEHOLDERS37
1.6SUMMARY OF CHANGES37
2RESEARCH METHODOLOGY38
2.1RESEARCH APPROACH38
2.2RESEARCH METHODOLOGY DESIGN38
FIGURE 1ECLINICAL SOLUTIONS MARKET: RESEARCH DESIGN38
2.2.1SECONDARY RESEARCH39
2.2.1.1Key data from secondary sources39
2.2.2PRIMARY DATA40
FIGURE 2PRIMARY SOURCES40
2.2.2.1Key data from primary sources41
2.2.2.2Insights from primary experts42
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS:
BY COMPANY, DESIGNATION, AND REGION43
2.3MARKET SIZE ESTIMATION: ECLINICAL SOLUTIONS MARKET43
FIGURE 4SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS44
FIGURE 5REVENUE SHARE ANALYSIS ILLUSTRATION44
FIGURE 6REVENUE ANALYSIS OF TOP 3 PUBLIC COMPANIES:
ECLINICAL SOLUTIONS MARKET (2020)45
FIGURE 7BOTTOM-UP APPROACH46
FIGURE 8CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ECLINICAL
SOLUTIONS MARKET (2021–2026)47
FIGURE 9CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS48
FIGURE 10TOP-DOWN APPROACH48
2.4MARKET BREAKDOWN & DATA TRIANGULATION49
FIGURE 11DATA TRIANGULATION METHODOLOGY49
2.5MARKET SHARE ESTIMATION50
2.6ASSUMPTIONS FOR THE STUDY50
2.7LIMITATIONS50
2.7.1METHODOLOGY-RELATED LIMITATIONS50
2.7.2SCOPE-RELATED LIMITATIONS51
2.8RISK ASSESSMENT51
TABLE 1RISK ASSESSMENT: ECLINICAL SOLUTIONS MARKET51
3EXECUTIVE SUMMARY52
FIGURE 12GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2021 VS. 2026 (USD MILLION)53
FIGURE 13GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2021 VS. 2026 (USD MILLION)54
FIGURE 14GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2021 VS. 2026 (USD MILLION)54
FIGURE 15GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2021 VS. 2026 (USD MILLION)55
FIGURE 16GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2020 (USD MILLION)56
4PREMIUM INSIGHTS57
4.1ECLINICAL SOLUTIONS: MARKET OVERVIEW57
FIGURE 17EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES DURING FORECAST PERIOD57
4.2NORTH AMERICA: ECLINICAL SOLUTIONS MARKET,
BY DELIVERY MODE AND COUNTRY (2020)58
FIGURE 18WEB-HOSTED DELIVERY MODE DOMINATED ECLINICAL
SOLUTIONS MARKET IN 202058
4.3ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE (2021 VS. 2026)58
FIGURE 19PHASE III CLINICAL TRIALS TO DOMINATE GLOBAL ECLINICAL SOLUTIONS MARKET DURING FORECAST PERIOD58
5MARKET OVERVIEW59
5.1INTRODUCTION59
5.2MARKET DYNAMICS59
FIGURE 20GLOBAL ECLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES59
5.2.1MAJOR MARKET DRIVERS60
5.2.1.1Increasing operational costs and regulatory requirements associated with clinical research studies60
5.2.1.2Growing adoption of novel software solutions in clinical research60
5.2.1.3Increased government funding and grants to support clinical trials61
5.2.1.4Need for improved data standardization61
5.2.1.5Increasing R&D expenditure on drug development pipeline by pharma-biotech companies62
5.2.1.6Growing customer base for eClinical solutions62
TABLE 2US: INDICATIVE LIST OF LIFE SCIENCE STARTUPS LAUNCHED
BETWEEN 2011 & 201563
5.2.2MAJOR MARKET RESTRAINTS63
5.2.2.1High implementation costs associated with eClinical solutions63
5.2.2.2Dearth of skilled professionals to operate eClinical solutions63
5.2.2.3Limited awareness of advantages of eClinical solutions among researchers64
5.2.3KEY GROWTH OPPORTUNITIES64
5.2.3.1Increasing clinical research activities in emerging Asian countries64
5.2.3.2Greater outsourcing of clinical trial processes to CROs64
5.2.3.3Rising number of clinical trials in emerging countries64
5.2.3.4Shift from manual data interpretation to real-time data analysis during clinical studies65
5.2.4MAJOR MARKET CHALLENGES65
5.2.4.1Limited adoption of eClinical solutions in developing nations65
5.2.4.2Concerns about software reliability65
5.2.4.3Patient privacy issues66
5.3IMPACT OF COVID-19 ON THE ECLINICAL SOLUTIONS MARKET66
5.4ECOSYSTEM ANALYSIS OF ECLINICAL SOLUTIONS MARKET67
FIGURE 21ECOSYSTEM ANALYSIS OF ECLINICAL SOLUTIONS MARKET67
5.5CASE STUDIES67
5.5.1YORK TEACHING HOSPITAL SPEEDS UP DATA CAPTURE PROCESS DURING PHASE III CLINICAL STUDY67
5.5.2LSHTM AND MENAFRICAR USE DATA CAPTURE SOFTWARE TO STUDY MENINGOCOCCAL CARRIAGE IN AFRICAN MENINGITIS BELT67
5.5.3CLINICAL TRIALS GROUP AT UCL USES EDC SYSTEM TO
CAPTURE AND VERIFY PATIENT FEEDBACK68
5.6VALUE CHAIN ANALYSIS68
FIGURE 22ECLINICAL SOLUTIONS : VALUE CHAIN68
5.7PORTER’S FIVE FORCES ANALYSIS68
TABLE 3HIGH CAPITAL INVESTMENTS TO RESTRICT ENTRY OF NEW PLAYERS68
5.7.1THREAT OF NEW ENTRANTS69
5.7.2THREAT OF SUBSTITUTES69
5.7.3BARGAINING POWER OF BUYERS69
5.7.4BARGAINING POWER OF SUPPLIERS69
5.7.5INTENSITY OF COMPETITIVE RIVALRY69
6GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT70
6.1INTRODUCTION71
TABLE 4GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)71
TABLE 5GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)72
6.2ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS72
TABLE 6GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)73
TABLE 7NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY,
2015–2018 (USD MILLION)73
TABLE 8GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)73
TABLE 9NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION)74
6.3CLINICAL TRIAL MANAGEMENT SYSTEMS74
TABLE 10GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)75
TABLE 11NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE,
BY COUNTRY, 2015–2018 (USD MILLION)75
TABLE 12GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)75
TABLE 13NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE,
BY COUNTRY, 2019–2026 (USD MILLION)76
6.4CLINICAL ANALYTICS PLATFORMS76
TABLE 14GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION)77
TABLE 15NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE,
BY COUNTRY, 2015–2018 (USD MILLION)77
TABLE 16GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)77
TABLE 17NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE,
BY COUNTRY, 2019–2026 (USD MILLION)78
6.5RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT78
TABLE 18GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)78
TABLE 19NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)79
TABLE 20GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)79
TABLE 21NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)79
6.6CLINICAL DATA INTEGRATION PLATFORMS79
TABLE 22GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE,
BY REGION, 2015–2018 (USD MILLION)80
TABLE 23NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)80
TABLE 24GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE,
BY REGION, 2019–2026 (USD MILLION)81
TABLE 25NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)81
6.7ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS81
TABLE 26GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)82
TABLE 27NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)82
TABLE 28GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)82
TABLE 29NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)83
6.8SAFETY SOLUTIONS83
TABLE 30GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION)83
TABLE 31NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY,
2015–2018 (USD MILLION)84
TABLE 32GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)84
TABLE 33NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION)84
6.9ELECTRONIC TRIAL MASTER FILE SYSTEMS84
TABLE 34GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE,
BY REGION, 2015–2018 (USD MILLION)85
TABLE 35NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE,
BY COUNTRY, 2015–2018 (USD MILLION)85
TABLE 36GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE,
BY REGION, 2019–2026 (USD MILLION)85
TABLE 37NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE,
BY COUNTRY, 2019–2026 (USD MILLION)86
6.10REGULATORY INFORMATION MANAGEMENT SOLUTIONS86
TABLE 38GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)86
TABLE 39NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE ,BY COUNTRY, 2015–2018 (USD MILLION)87
TABLE 40GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)87
TABLE 41NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)87
6.11OTHER ECLINICAL SOLUTIONS88
TABLE 42GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION)88
TABLE 43NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION)88
TABLE 44GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)89
TABLE 45NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)89
7ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE90
7.1INTRODUCTION91
TABLE 46GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2015–2018 (USD MILLION)91
TABLE 47GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2019–2026 (USD MILLION)91
7.2WEB-HOSTED (ON-DEMAND) SOLUTIONS91
TABLE 48WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION)92
TABLE 49WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)92
7.3LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS92
TABLE 50LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION)93
TABLE 51LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)93
7.4CLOUD-BASED (SAAS) SOLUTIONS94
TABLE 52CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION)95
TABLE 53CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)95
8GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE96
8.1INTRODUCTION97
FIGURE 23PHASE III TRIALS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD97
TABLE 54GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)97
TABLE 55GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)98
8.2PHASE I CLINICAL TRIALS98
TABLE 56ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS,
BY REGION, 2015–2018 (USD MILLION)98
TABLE 57ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS,
BY REGION, 2019–2026 (USD MILLION)99
8.3PHASE II CLINICAL TRIALS99
TABLE 58ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS,
BY REGION, 2015–2018 (USD MILLION)100
TABLE 59ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS,
BY REGION, 2019–2026 (USD MILLION)100
8.4PHASE III CLINICAL TRIALS100
TABLE 60ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS,
BY REGION, 2015–2018 (USD MILLION)101
TABLE 61ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS,
BY REGION, 2019–2026 (USD MILLION)101
8.5PHASE IV CLINICAL TRIALS102
TABLE 62ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS,
BY REGION, 2015–2018 (USD MILLION)102
TABLE 63ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS,
BY REGION, 2019–2026 (USD MILLION)102
9ECLINICAL SOLUTIONS MARKET, BY END USER103
9.1INTRODUCTION104
FIGURE 24GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER (2020)104
TABLE 64GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION)104
TABLE 65GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)105
9.2PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES105
TABLE 66ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015–2018 (USD MILLION)106
TABLE 67ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2019–2026 (USD MILLION)106
9.3CONTRACT RESEARCH ORGANIZATIONS106
TABLE 68KEY STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011–2015)107
TABLE 69ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION,
2015–2018 (USD MILLION)107
TABLE 70ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION,
2019–2026 (USD MILLION)108
9.4CONSULTING SERVICE COMPANIES108
TABLE 71ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2015–2018 (USD MILLION)109
TABLE 72ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2019–2026 (USD MILLION)109
9.5MEDICAL DEVICE MANUFACTURERS109
TABLE 73ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2015–2018 (USD MILLION)110
TABLE 74ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2019–2026 (USD MILLION)110
9.6HOSPITALS110
TABLE 75ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION,
2015–2018 (USD MILLION)111
TABLE 76ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION,
2019–2026 (USD MILLION)111
9.7ACADEMIC RESEARCH INSTITUTES111
TABLE 77ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015–2018 (USD MILLION)112
TABLE 78ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)112
10ECLINICAL SOLUTIONS MARKET, BY REGION113
10.1INTRODUCTION114
FIGURE 25GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2021 VS. 2026 (USD MILLION)114
TABLE 79GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION)115
TABLE 80GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)115
10.2NORTH AMERICA116
FIGURE 26NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT116
TABLE 81NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2015–2018 (USD MILLION)117
TABLE 82NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION)117
TABLE 83NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)117
TABLE 84NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)118
TABLE 85NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)118
TABLE 86NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)118
TABLE 87NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)119
TABLE 88NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)119
TABLE 89NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)119
TABLE 90NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)120
10.2.1US120
10.2.1.1Availability of government funding for clinical research to drive market growth120
TABLE 91US: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)121
TABLE 92US: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)122
TABLE 93US: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)122
TABLE 94US: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)122
TABLE 95US: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015–2018 (USD MILLION)123
TABLE 96US: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2019–2026 (USD MILLION)123
TABLE 97US: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION)123
TABLE 98US: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)124
10.2.2CANADA124
10.2.2.1Government support to contribute to market growth124
TABLE 99CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)125
TABLE 100CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)125
TABLE 101CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)126
TABLE 102CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)126
TABLE 103CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)126
TABLE 104CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)127
TABLE 105CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION)127
TABLE 106CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)127
10.3EUROPE128
FIGURE 27EUROPE: ECLINICAL SOLUTIONS MARKET SNAPSHOT128
TABLE 107EMA-APPROVED BIOSIMILARS129
TABLE 108EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2015–2018 (USD MILLION)132
TABLE 109EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION)132
TABLE 110EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)133
TABLE 111EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)133
TABLE 112EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)134
TABLE 113EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)134
TABLE 114EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)134
TABLE 115EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)135
TABLE 116EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION)135
TABLE 117EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)135
10.3.1GERMANY136
10.3.1.1Increasing R&D investments and initiatives to boost market growth136
TABLE 118GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)136
TABLE 119GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)137
TABLE 120GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)137
TABLE 121GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)137
TABLE 122GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)138
TABLE 123GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)138
TABLE 124GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION)138
TABLE 125GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)139
10.3.2UK139
10.3.2.1Favorable R&D scenario to boost software adoption139
TABLE 126UK: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)140
TABLE 127UK: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)140
TABLE 128UK: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)141
TABLE 129UK: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)141
TABLE 130UK: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015–2018 (USD MILLION)141
TABLE 131UK: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2019–2026 (USD MILLION)142
TABLE 132UK: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION)142
TABLE 133UK: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)142
10.3.3FRANCE143
10.3.3.1High number of oncology clinical trials to drive market growth143
TABLE 134FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)143
TABLE 135FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)144
TABLE 136FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)144
TABLE 137FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)144
TABLE 138FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)145
TABLE 139FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)145
TABLE 140FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION)145
TABLE 141FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)146
10.3.4ITALY146
10.3.4.1Low drug approval times drive growing adoption of eClinical solutions146
TABLE 142NUMBER OF CLINICAL TRIALS STARTED IN ITALY, BY COMPANY, 2017146
TABLE 143ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)147
TABLE 144ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)147
TABLE 145ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)148
TABLE 146ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)148
TABLE 147ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)148
TABLE 148ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)149
TABLE 149ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION)149
TABLE 150ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)149
10.3.5SPAIN150
10.3.5.1Rising R&D expenditure to propel market growth150
TABLE 151SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)150
TABLE 152SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)151
TABLE 153SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)151
TABLE 154SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)151
TABLE 155SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)152
TABLE 156SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)152
TABLE 157SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION)152
TABLE 158SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)153
10.3.6REST OF EUROPE153
TABLE 159REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)154
TABLE 160REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)154
TABLE 161REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)155
TABLE 162REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)155
TABLE 163REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)155
TABLE 164REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)156
TABLE 165REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018(USD MILLION)156
TABLE 166REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)156
10.4ASIA-PACIFIC157
FIGURE 28ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SNAPSHOT157
TABLE 167ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2015–2018 (USD MILLION)159
TABLE 168ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION)159
TABLE 169ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)160
TABLE 170ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)160
TABLE 171ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)161
TABLE 172ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)161
TABLE 173ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)161
TABLE 174ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)162
TABLE 175ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION)162
TABLE 176ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)162
10.4.1CHINA163
10.4.1.1Low cost of clinical trials and large pharmaceutical R&D base to drive market growth163
TABLE 177CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)163
TABLE 178CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)164
TABLE 179CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)164
TABLE 180CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)164
TABLE 181CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)165
TABLE 182CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)165
TABLE 183CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION)165
TABLE 184CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)166
10.4.2JAPAN166
10.4.2.1Stringent regulatory scenario to restrain market growth166
TABLE 185JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)166
TABLE 186JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)167
TABLE 187JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)167
TABLE 188JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)167
TABLE 189JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)168
TABLE 190JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)168
TABLE 191JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION)168
TABLE 192JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)169
10.4.3INDIA169
10.4.3.1Favorable pharmaceutical R&D scenario to drive software adoption169
TABLE 193INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION)170
TABLE 194INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION)170
TABLE 195INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION)171
TABLE 196INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION)171
TABLE 197INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)171
TABLE 198INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)172
TABLE 199INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION)172
TABLE 200INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION)172
10.4.4REST OF ASIA PACIFIC173
TABLE 201REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)173
TABLE 202REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)173
TABLE 203REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)174
TABLE 204REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)174
TABLE 205REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)174
TABLE 206REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)175
TABLE 207REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)175
TABLE 208REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)175
10.5REST OF THE WORLD176
FIGURE 29ROW: ECLINICAL SOLUTIONS MARKET SNAPSHOT176
TABLE 209REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION)177
TABLE 210REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION)178
TABLE 211REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION)178
TABLE 212REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION)178
TABLE 213REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION)179
TABLE 214REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION)179
TABLE 215REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION)179
TABLE 216REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION)180
11COMPETITIVE LANDSCAPE181
11.1INTRODUCTION181
11.2RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS181
FIGURE 30ECLINICAL SOLUTIONS MARKET: STRATEGIES ADOPTED181
11.3REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS182
FIGURE 31KEY PLAYERS IN ECLINICAL SOLUTIONS MARKET182
11.4MARKET SHARE ANALYSIS183
FIGURE 32GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2020183
11.5COMPANY EVALUATION QUADRANT183
11.5.1STARS184
11.5.2EMERGING LEADERS184
11.5.3PERVASIVE PLAYERS184
11.5.4PARTICIPANTS184
FIGURE 33ECLINICAL SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT, 2020185
11.6ECLINICAL SOLUTIONS MARKET: SME EVALUATION186
11.6.1PROGRESSIVE COMPANIES186
11.6.2STARTING BLOCKS186
11.6.3RESPONSIVE COMPANIES186
11.6.4DYNAMIC COMPANIES186
FIGURE 34ECLINICAL SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT FOR SMES, 2020187
11.7COMPETITIVE BENCHMARKING188
11.7.1COMPANY SERVICE FOOTPRINT (25 COMPANIES)188
FIGURE 35COMPANY PORTFOLIO FOOTPRINT: ECLINICAL SOLUTIONS MARKET188
TABLE 217COMPANY REGION FOOTPRINT (25 COMPANIES)189
11.8COMPETITIVE SITUATIONS AND TRENDS190
11.8.1PRODUCT/SERVICE LAUNCHES190
TABLE 218PRODUCT/SERVICE LAUNCHES (2018 TO 2021)190
11.8.2DEALS191
TABLE 219DEALS191
TABLE 220OTHER DEVELOPMENTS194
12COMPANY PROFILES195
(Business Overview, Products & services Offered, Recent Developments, and Right to win)*
12.1KEY PLAYERS195
12.1.1ORACLE CORPORATION.195
TABLE 221ORACLE CORPORATION: BUSINESS OVERVIEW195
FIGURE 36ORACLE CORPORATION: COMPANY SNAPSHOT (2020)196
12.1.2DASSAULT SYSTÈMES199
TABLE 222DASSAULT SYSTÈMES: BUSINESS OVERVIEW199
FIGURE 37DASSAULT SYSTÈMES: COMPANY SNAPSHOT (2020)200
12.1.3PAREXEL INTERNAT

Report Title: eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW